Lilly’s Next-Gen Weight Loss Shot Cuts Body Weight by 28% in Study
Culture Index
Score Breakdown
Relevance
3/25
Freshness
23/25
Authority
25/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
Nearly half of patients who got a high dose of Eli Lilly's experimental obesity shot retatrutide lost the equivalent weight of bariatric surgery, sending the drugmaker's shares up in premarket trading.
